Should HIV patients be considered a high risk group for the development of prostate cancer?

By Quatan Nadine   Nair Sabarinath   Harrowes Fran   Hay Phillip  

Annals of The Royal College of Surgeons of England, Vol. 87, Iss. 6, 2005-11 ,pp. : 437-438

The Royal College of Surgeons of England

Access to resources Recommend Favorite

Predictive factor analysis as the basis for the clinical utility of percent positive prostate biopsies in patients with intermediate-risk prostate cancer

By Yoon J.H.   Chen M.-H.   Renshaw A.A.   Richie J.P.   D'Amico A.V.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 454-457

Elsevier

Access to resources Recommend Favorite

Repeat transrectal ultrasound-guided prostate biopsy: a strategy to improve the reliability of needle biopsy grading in patients with well-differentiated prostate cancer - a perspective

By Fleshner N.E.   Cookson M.S.   Soloway S.M.   Fair W.R.  

Urology, Vol. 52, Iss. 4, 1998-10 ,pp. : 659-662

Elsevier

Access to resources Recommend Favorite

Genetic polymorphisms and prostate cancer risk

By Gsur Andrea  

World Journal of Urology, Vol. 21, Iss. 6, 2004-02 ,pp. : 414-423

Springer Publishing Company

Access to resources Recommend Favorite

The face of high risk prostate cancer

By Albertsen Peter  

World Journal of Urology, Vol. 26, Iss. 3, 2008-06 ,pp. : 205-210

Springer Publishing Company

Access to resources Recommend Favorite